WO2022248665 - COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION
National phase entry:
Publication Number
WO/2022/248665
Publication Date
01.12.2022
International Application No.
PCT/EP2022/064408
International Filing Date
27.05.2022
Title **
[English]
COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION
[French]
COMPOSITIONS ET MÉTHODES POUR INHIBER L'EXPRESSION DU COMPOSANT 1 RÉDUCTEUR D'AMIDOXIME MITOCHONDRIALE (MARC1)
Applicants **
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
DICERNA PHARMACEUTICALS, INC.
75 Hayden Avenue
Lexington, 02421, US
Inventors
DUDEK, Henryk
Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington, MA02421, US
HAN, Wen
Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington, MA02421, US
PURSELL, Natalie, Wayne
Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington, MA02421, US
LAI, Chengjung
Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington, MA02421, US
HAYNES, William, Geoffrey
Novo Nordisk Ltd.
Old Road Campus Roosevelt Drive
Oxford OX3 7FZ, GB
DING, Zhihao
Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd Building #2/#4, Bio-tech R&D Center, No.20 Life Science Park Road
Beijing, Beijing 102206, CN
Priority Data
63/194,395
28.05.2021
US
21183860.2
06.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2624 | |
| EPO | Filing, Examination | 8686 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 608 | |
| USA | Filing, Examination | 7060 |
Total: 19572 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
expression.[French]
.